697 related articles for article (PubMed ID: 38438349)
1. New clinical trial design in precision medicine: discovery, development and direction.
Duan XP; Qin BD; Jiao XD; Liu K; Wang Z; Zang YS
Signal Transduct Target Ther; 2024 Mar; 9(1):57. PubMed ID: 38438349
[TBL] [Abstract][Full Text] [Related]
2. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
Janiaud P; Serghiou S; Ioannidis JPA
Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
[TBL] [Abstract][Full Text] [Related]
3. An overview of precision oncology basket and umbrella trials for clinicians.
Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
[TBL] [Abstract][Full Text] [Related]
4. Novel Study Designs in Precision Medicine - Basket, Umbrella and Platform Trials.
Ravi R; Kesari HV
Curr Rev Clin Exp Pharmacol; 2022; 17(2):114-121. PubMed ID: 34455953
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial design in the era of precision medicine.
Fountzilas E; Tsimberidou AM; Vo HH; Kurzrock R
Genome Med; 2022 Aug; 14(1):101. PubMed ID: 36045401
[TBL] [Abstract][Full Text] [Related]
6. Umbrella and basket trials in oncology: ethical challenges.
Strzebonska K; Waligora M
BMC Med Ethics; 2019 Aug; 20(1):58. PubMed ID: 31443704
[TBL] [Abstract][Full Text] [Related]
7. Challenges, opportunities, and innovative statistical designs for precision oncology trials.
Yin J; Shen S; Shi Q
Ann Transl Med; 2022 Sep; 10(18):1038. PubMed ID: 36267789
[TBL] [Abstract][Full Text] [Related]
8. New clinical trial designs for establishing drug efficacy and safety in a precision medicine era.
Heerspink HJL; List J; Perkovic V
Diabetes Obes Metab; 2018 Oct; 20 Suppl 3(Suppl Suppl 3):14-18. PubMed ID: 30294954
[TBL] [Abstract][Full Text] [Related]
9. [Application of umbrella design and basket design in evidence-based research for traditional Chinese medicine].
Guo XH; Huang Q; Xie YM; Wen ZH
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):2010-2015. PubMed ID: 33982513
[TBL] [Abstract][Full Text] [Related]
10. Light and shadow on innovative clinical trial designs: reflections from the EORTC-PAMM course on 'preclinical and early-phase clinical pharmacology'.
Leonetti A; Boyd L; Giuliani J; Giovannetti E; Garajová I
Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1033-1036. PubMed ID: 31633383
[No Abstract] [Full Text] [Related]
11. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols.
Park JJH; Siden E; Zoratti MJ; Dron L; Harari O; Singer J; Lester RT; Thorlund K; Mills EJ
Trials; 2019 Sep; 20(1):572. PubMed ID: 31533793
[TBL] [Abstract][Full Text] [Related]
12. Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials.
Lu CC; Li XN; Broglio K; Bycott P; Jiang Q; Li X; McGlothlin A; Tian H; Ye J
Ther Innov Regul Sci; 2021 Nov; 55(6):1145-1154. PubMed ID: 34160785
[TBL] [Abstract][Full Text] [Related]
13. Types and progress of clinical trial design for breast cancer: a narrative review.
Zhou T; Zhang J
Transl Breast Cancer Res; 2023; 4():20. PubMed ID: 38751463
[TBL] [Abstract][Full Text] [Related]
14. Biomarker-Driven Oncology Clinical Trials: Novel Designs in the Era of Precision Medicine.
Moore DC; Guinigundo AS
J Adv Pract Oncol; 2023 Apr; 14(Suppl 1):9-13. PubMed ID: 37206904
[TBL] [Abstract][Full Text] [Related]
15. Biostatistical and Logistical Considerations in the Development of Basket and Umbrella Clinical Trials.
Yee LM; McShane LM; Freidlin B; Mooney MM; Korn EL
Cancer J; 2019; 25(4):254-263. PubMed ID: 31335389
[TBL] [Abstract][Full Text] [Related]
16. New clinical trial designs in the era of precision medicine.
Garralda E; Dienstmann R; Piris-Giménez A; Braña I; Rodon J; Tabernero J
Mol Oncol; 2019 Mar; 13(3):549-557. PubMed ID: 30698321
[TBL] [Abstract][Full Text] [Related]
17. Challenges with Novel Clinical Trial Designs: Master Protocols.
Cecchini M; Rubin EH; Blumenthal GM; Ayalew K; Burris HA; Russell-Einhorn M; Dillon H; Lyerly HK; Reaman GH; Boerner S; LoRusso PM
Clin Cancer Res; 2019 Apr; 25(7):2049-2057. PubMed ID: 30696689
[TBL] [Abstract][Full Text] [Related]
18. Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design.
Fountzilas E; Tsimberidou AM; Hiep Vo H; Kurzrock R
Cancer Treat Rev; 2024 Apr; 125():102703. PubMed ID: 38484408
[TBL] [Abstract][Full Text] [Related]
19. The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review.
Meyer EL; Mesenbrink P; Dunger-Baldauf C; Fülle HJ; Glimm E; Li Y; Posch M; König F
Clin Ther; 2020 Jul; 42(7):1330-1360. PubMed ID: 32622783
[TBL] [Abstract][Full Text] [Related]
20. Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials.
Di Liello R; Piccirillo MC; Arenare L; Gargiulo P; Schettino C; Gravina A; Perrone F
Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]